Vimarsana
Biggest News Aggregation in the World

Multiple Dose Vials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Dose Vials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Dose Vials Today - Breaking & Trending Today

Lupin : November 8, 2023 Lupin Launches Rocuronium Bromide Injection in the United States -November 10, 2023 at 04:39 pm EST - Vimarsana News

Lupin : November 8, 2023 Lupin Launches Rocuronium Bromide Injection in the United States -November 10, 2023 at 04:39 pm EST

Mumbai, Baltimore, November 08, 2023: Global pharma major Lupin Limited today announced the launch of Rocuronium Bromide Injection, 50 mg/5 mL and 100 mg/10 mL Multiple-Dose Vials,...

Lupin Launches Thiamine Hydrochloride Injection USP In The United States - Vimarsana News

Lupin Launches Thiamine Hydrochloride Injection USP In The United States

Thiamine Hydrochloride Injection USP had estimated annual sales of USD 35 million in the U.S.

Caplin Steriles Ltd receives final approval from USFDA for ANDA Cisatracurium Besylate Injection USP - Vimarsana News

Caplin Steriles Ltd receives final approval from USFDA for ANDA Cisatracurium Besylate Injection USP

Caplin Steriles Ltd, a Subsidiary company of Caplin Point Laboratories Ltd, has been granted final approval from the United States Food and Drug Administration for its ANDA Cisatracurium Besylate Injection USP.

Lupin's Alliance Partner Caplin Receives U.S. FDA Approval for Thiamine Hydrochloride Injection USP - Vimarsana News

Lupin's Alliance Partner Caplin Receives U.S. FDA Approval for Thiamine Hydrochloride Injection USP

Global pharma major Lupin Ltd today announced that its alliance partner Caplin Steriles Ltd has received final approval from the United States Food and Drug Administration for its Abbreviated new Drug Application.

Alembic Pharmaceuticals gets USFDA final approval for ANDA Docetaxel Injection - Vimarsana News

Alembic Pharmaceuticals gets USFDA final approval for ANDA Docetaxel Injection

Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application Docetaxel Injection.